FXR not required for inflammation during cholestasis

Archie Digital Collections

Show simple item record

dc.contributor.author Allen, Katryn
dc.date.accessioned 2006-07-05T21:15:12Z
dc.date.available 2006-07-05T21:15:12Z
dc.date.issued 2006-07-05T21:15:12Z
dc.identifier.uri http://hdl.handle.net/2271/170
dc.description Genetics Room G026 Dykes 3:12 PM Abstract 169 en
dc.description.abstract Cholestasis is a condition that results when excretion of bile acids from the liver is interrupted. Liver injury occurs in both humans and animals as a result of cholestasis, and recent studies have shown that inflammation is required for injury. The mechanism by which cholestasis increases production of proinflammatory mediators is not completely understood. One recent study showed that farnesoid X receptor (FXR), a bile acid nuclear receptor, upregulates proinflammatory mediators in response to bile acids in vitro. This suggests that FXR is important for inflammation during cholestasis. To test this hypothesis in vivo, wild-type and FXR knockout mice were subjected to bile duct ligation (BDL), a commonly used model of cholestasis. Three days later, levels of intercellular adhesion molecule-1 (ICAM-1) and macrophage inflammatory protein-2 (MIP-2), both important for the recruitment of neutrophils to the liver, were measured. ICAM-1 levels were increased to a similar extent in wild-type and FXR knockouts subjected to BDL. MIP-2 levels increased after BDL, and induction of MIP-2 in FXR knockouts was three times greater than in wild-types. Neutrophil numbers in liver were quantified and found to be elevated to a similar extent in wild-types and FXR knockouts after BDL. Next, liver injury was evaluated by measuring serum levels of alanine aminotransferase (ALT), an indicator of hepatocyte injury. ALT levels were significantly elevated in wild-type mice subjected to BDL, and was further increased in FXR knockouts after BDL. Results from these studies suggest that inflammation in liver occurs independently of FXR during cholestasis. en
dc.description.sponsorship Copple, Bryan Pharmacology, Toxicology and Therapeutics en
dc.format.extent 3324416 bytes
dc.format.mimetype application/vnd.ms-powerpoint
dc.language.iso en_US en
dc.subject farnesoid X receptor en
dc.subject cholestasis en
dc.subject ICAM-1 en
dc.subject MIP-2 en
dc.title FXR not required for inflammation during cholestasis en
dc.type Presentation en

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Archie


Advanced Search

Browse

My Account

Statistics